![Yumi Matsuzaki](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cargos activos de Yumi Matsuzaki
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
PuREC KK
![]() PuREC KK BiotechnologyHealth Technology PuREC KK is a company based in Japan that aims to revolutionize the future of regenerative medicine by developing a high-purity mesenchymal stem cell culture technology called REC (Rapidly Expanding Cell). REC has approximately 1000 times more pharmacological efficacy in terms of proliferation and differentiation compared to normal mesenchymal stem cells, making it effective in treating a wide range of diseases. The Japanese company was founded in 2016 by Shotai Kobayashi. | Director/Miembro de la Junta | - | - |
Director Técnico/Científico/I+D | - | - |
Historial de carrera de Yumi Matsuzaki
Estadísticas
Internacional
Japón | 2 |
Operativa
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorial
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
PuREC KK
![]() PuREC KK BiotechnologyHealth Technology PuREC KK is a company based in Japan that aims to revolutionize the future of regenerative medicine by developing a high-purity mesenchymal stem cell culture technology called REC (Rapidly Expanding Cell). REC has approximately 1000 times more pharmacological efficacy in terms of proliferation and differentiation compared to normal mesenchymal stem cells, making it effective in treating a wide range of diseases. The Japanese company was founded in 2016 by Shotai Kobayashi. | Health Technology |
- Bolsa de valores
- Insiders
- Yumi Matsuzaki
- Experiencia